{"podcast":{"title":"Few & Far Between: How Biotech Gets Built","slug":"few-far-between-how-biotech-gets-built-4067896","podcast_index_feed_id":4067896,"rss_url":"https://feeds.castos.com/kd1o1","website_url":"https://biorasi.com/few-far-between-podcast/","image_url":"https://episodes.castos.com/6026d270a471b8-76273800/images/podcast/covers/c1a-7krkv-5zqr8dopfxo9-ndltai.jpg","author":"Adam Gottlieb","episode_count":35,"summary":"Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896"},"episode":{"title":"Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®","slug":"episode-55-julio-g-martinez-clark-ceo-and-co-founder-at-bioaccess","published_at":"2025-07-09T09:23:00+00:00","page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-55-julio-g-martinez-clark-ceo-and-co-founder-at-bioaccess","show_page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896","url":"https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-56-julio-g-martinez-clark-ceo-and-co-founxst","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2083782/c1e-q414ghdd3wdhnr8pp-z3kzq6d4idk4-dchrde.mp3","summary":"How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks of running studies in this region. In our latest episode of the Biorasi Few & Far Between podcast, host Chris O'Brien welcomes Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®. Tune in as we spotlight the advantages of running studies in #LATAM - from data quality to speed to approval.","meta_description":"How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks of running studies in this regi…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2326,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-55-julio-g-martinez-clark-ceo-and-co-founder-at-bioaccess/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-55-julio-g-martinez-clark-ceo-and-co-founder-at-bioaccess.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}